Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Crotamiton 10% lotion
1303000I0AAABAB
|
Crotamiton | Crotamiton | Skin | No data available |
|
Cuplex Verruca gel
1307000M0BLAAAX
|
Cuplex | Salicylic acid | Skin | No data available |
|
CX 1% powder
1311020G0BEAAAH
|
Cx 1 | Chlorhexidine acetate | Skin | No data available |
|
Cyproterone 2mg capsules
1306020D0AAACAC
|
Cyprote acetate (Acne) | Cyproterone acetate | Skin | No data available |
|
Daktarin Aktiv 2% powder
1310020N0BBAFAB
|
Daktarin (Miconazole nitrate) | Miconazole nitrate | Skin | No data available |
|
DDD medicated cream
1306010S0BCAAA0
|
DDD (Topical) | Resorcinol | Skin | No data available |
|
DDD medicated lotion
1306010S0BCABA0
|
DDD (Topical) | Resorcinol | Skin | No data available |
|
Decubal Clinic cream
130201000BBBKA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Delacet herbal head lice solution
131004000BPADA0
|
Proprietary compound preparation BNF 1310040 | Other parasiticidal preparations | Skin | No data available |
|
Delgocitinib 20mg/g cream
1305030M0AAAAAA
|
Delgocitinib | Delgocitinib | Skin | No data available |
|
Delph sun lotion SPF 15
130801000BBLGA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Delph sun lotion SPF 20
130801000BBLNA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Delph sun lotion SPF 25
130801000BBLJA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Dermablend compact cover creme chroma
130802000BBCHA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme B12 medium beige
130802000BBCZA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme B34 golden beige
130802000BBDAA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme B56 warm ivory
130802000BBDBA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme B78 sand beige
130802000BBDCA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme cafe
130802000BBDKA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme chocolate
130802000BBDLA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme chroma
130802000BBBNA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme G12 honey beige
130802000BBDDA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme G34 olive brown
130802000BBDEA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme G56 chocolate brown
130802000BBDFA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
|
Dermablend cover creme G78 true beige
130802000BBDGA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.